2 day workshop on WTD 12th October Information stand in outpatient waiting room to raise public awarness 13th October invitation to Health care professionals to attend the WTD presentation on hospital acquired thrombosis

Contaremos con la presencia de médicos del staff de Clínica San Camilo. Quien llevará adelante la jornada es la Dra. Vilaseca jefa del servicio de Hematología y la acompañarán el Dr. Pastoriza, la Dra. Kutja y la Dra. Begue. Contaremos con la colaboración de Suizo Argentina SA Alumnos del Insituto Padre Luis Tezza participarán activamente con la difusión en la vía pública. ¡Los esperamos!

Thrombosis Canada invites you to join us for our 2022 annual meeting on October 15 in Toronto. With a wide range of topics and speakers, the program aims to meet the needs of a wide range of healthcare professionals including hematologists, internists, primary care physicians, nurses/nurse practitioners and pharmacists.

The meeting will be available in-person as well as streamed on Zoom on October 15.

The learning objectives for the program are as follows:

After completing this program, participants will be equipped to:

•            Apply current evidence in the management of patients with thrombotic disease

•            Manage thrombosis challenges in clinical practice

•            Implement thrombosis treatment options in a variety of patient populations

This Group Learning program has been reviewed by the College of Family Physicians of Canada and is awaiting final certification from the College’s Ontario Chapter.

The Canadian Council on Continuing Education in Pharmacy has accredited this program for 9.75 CEUs.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by the University of Calgary Office of Continuing Medical Education and Professional Development. You may claim a maximum of 7 hours (credits are automatically calculated).

You're invited to take part in a very special 5K Run/Walk event in honor of a late Henderson, Kentucky man.

In November 2020, Nick Payne passed away suddenly due to deep vein thrombosis.  Since his passing, it has become his family's mission to raise awareness about this is our dangerous medical condition with the hope of preventing further lives from being lost to a potentially treatable condition.

This event will be held on Saturday, October 8th at Sandy Lee Watkins Park in Henderson, Kentucky.

Late Registration/Packet Pick-up begins at 7:30 a.m. and the race starts at 9 a.m., and the race starts at 9:00 a.m. The fee to enter into the 5K is $20.00 per person, with children 8 and under free. 100% of all proceeds/donations will go back to the World Thrombosis Day Campaign.

You can register now by clicking here: https://www.riseupandrun.com/event/world-thrombosis-day-nick-payne-memorial-5k/ 

Pulmonary embolism (PE) remains one of the leading causes of maternal deaths worldwide, including in Singapore. This symposium will be held on World Thrombosis Day 2022 to highlight key strategies to prevent venous thromboembolism for at-risk mothers and raise awareness about new therapies which can reduce morbidity and mortality from PE. This event is supported by the Obstetrical & Gynaecological Society of Singapore, jointly organised by Cardinal Health, Healthcare Essentials and Pregnancy Singapore.

Following the success of the BMS-Pfizer Alliance’s 2020 and 2021 policy webcasts on stroke prevention, the Alliance is delighted to invite you to a third policy roundtable on how the European Union’s (EU) non-communicable disease (NCD) initiative can inspire better outcomes for stroke patients. The event, entitled ‘Driving the EU’s Non-Communicable Disease Initiative: sharing best practices and empowering equal access to stroke prevention and care’, will take place on Wednesday 12 October from 15.00 – 16.30 CEST. Invitees can join either via Zoom or in person at the Thon Hotel EU, Rue de la Loi 75, 1040 Brussels. The webcast will be available in English and will be translated into French and Spanish. Interested participants may apply for registration at the following link. The panel discussion will bring a range of health policy and stroke and CVD expertise to the table, facilitated by experienced health policy moderator, Brian Maguire from EurActiv, including: • Arlene Wilkie, Director General, Stroke Alliance for Europe • Dr. Valeria Caso, Former President, European Stroke Organisation • Trudie Lobban (MBE), CEO and Founder, Atrial Fibrillation Association • Artur Furtado, Deputy Head of Unit, European Commission • Sara Cerdas, Member of the European Parliament (S&D, PT) • Health Attaché, Permanent Representation to the EU (tbc) The EU has just published its first ever initiative focused on combating NCDs in Europe. Arriving as our healthcare systems face increased economic pressure, this action is incredibly timely. If harnessed completely, it has huge potential to drive policy action focused on disease prevention, diagnosis, treatment and care that will both improve the lives of patients across Europe and protect healthcare system sustainability. Cardiovascular diseases (CVD), including stroke, are prioritised by the Initiative, having not previously been formally recognized and placed on the EU’s health policy agenda. This is welcome given beliefs that stroke is a health crisis still not addressed appropriately by policymakers. Despite being highly preventable, including through monitoring and screening, stroke remains a leading cause of death and disability in Europe. An estimated 1 in 4 people are likely to have a stroke during their lifetime, and it cost 32 European countries a total of €60 billion in 2017 alone . Whilst this renewed focus is welcome, EU level action is only the beginning for Europe on stroke prevention. The coming months will require better, effective stakeholder participation to translate these good ideas into policies that are taken up by Member States, ultimately leading to better patient outcomes. This is particularly important for Atrial Fibrillation (AF) related stroke, which will be addressed separately to the majority of stroke. Bringing together key policymakers, researchers, and advocacy organizations, our goal is to advance the discussion on how the NCD Initiative can help empower Member States to take decisive action to ensure better pathways for stroke patients, whilst ensuring early prevention measures are scaled up. Interested participants may apply for registration at the following link. Disclaimer: *This Webcast is sponsored by The Bristol Myers Squibb–Pfizer Alliance; the findings, views and opinions expressed are those of the participants. They do not reflect the findings, views and opinions of The Bristol Myers Squibb–Pfizer Alliance.

Zapraszamy na Światowy Dzień Zakrzepicy pod patronatem Polskiego Towarzystwa Flebologicznego. Konferencja odbędzie się w Warszawie 13 października 2022 r. Udział w konferencji jest bezpłatny dla wszystkich lekarzy.

Educational Webinar with Live Q&A to discuss prevention of Hospital Acquired VTE. See link for featured speakers and topics